Cog 2891 study regimen
Cog 2891 study regimen - an induction regimen consisting of dexamethasone, cytarabine, thioguanine, etoposide and daunorubucin (or rubidomycin), administered on an intensively timed schedule as a form of timed sequential therapy and used for the treatment of childhood acute myeloid leukemia.
Latest articles Cog 2891 study regimen
|This medical article is a stub. You can help WikiMD by expanding it.|
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Cog 2891 study regimen for any updates.